Matches in Wikidata for { <http://www.wikidata.org/entity/Q96302965> ?p ?o ?g. }
- Q96302965 description "2020 nî lūn-bûn" @default.
- Q96302965 description "2020 թվականի հունիսի 10-ին հրատարակված գիտական հոդված" @default.
- Q96302965 description "2020年の論文" @default.
- Q96302965 description "2020年学术文章" @default.
- Q96302965 description "2020年学术文章" @default.
- Q96302965 description "2020年学术文章" @default.
- Q96302965 description "2020年学术文章" @default.
- Q96302965 description "2020年学术文章" @default.
- Q96302965 description "2020年学术文章" @default.
- Q96302965 description "2020年學術文章" @default.
- Q96302965 description "2020年學術文章" @default.
- Q96302965 description "2020年學術文章" @default.
- Q96302965 description "2020年學術文章" @default.
- Q96302965 description "2020年學術文章" @default.
- Q96302965 description "2020년 논문" @default.
- Q96302965 description "article científic" @default.
- Q96302965 description "article scientific" @default.
- Q96302965 description "article scientifique" @default.
- Q96302965 description "articol științific" @default.
- Q96302965 description "articolo scientifico" @default.
- Q96302965 description "artigo científico" @default.
- Q96302965 description "artigo científico" @default.
- Q96302965 description "artigo científico" @default.
- Q96302965 description "artikel ilmiah" @default.
- Q96302965 description "artikull shkencor" @default.
- Q96302965 description "artikulong pang-agham" @default.
- Q96302965 description "artykuł naukowy" @default.
- Q96302965 description "artículo científico publicado en 2020" @default.
- Q96302965 description "artículu científicu" @default.
- Q96302965 description "bilimsel makale" @default.
- Q96302965 description "bài báo khoa học" @default.
- Q96302965 description "naučni članak" @default.
- Q96302965 description "scienca artikolo" @default.
- Q96302965 description "scientific article published on 10 June 2020" @default.
- Q96302965 description "scientific article published on 10 June 2020" @default.
- Q96302965 description "scientific article published on 10 June 2020" @default.
- Q96302965 description "teaduslik artikkel" @default.
- Q96302965 description "tieteellinen artikkeli" @default.
- Q96302965 description "tudományos cikk" @default.
- Q96302965 description "vedecký článok" @default.
- Q96302965 description "vetenskaplig artikel" @default.
- Q96302965 description "videnskabelig artikel udgivet 10. juni 2020" @default.
- Q96302965 description "vitenskapelig artikkel" @default.
- Q96302965 description "vitskapeleg artikkel" @default.
- Q96302965 description "vědecký článek" @default.
- Q96302965 description "wetenschappelijk artikel" @default.
- Q96302965 description "wissenschaftlicher Artikel" @default.
- Q96302965 description "επιστημονικό άρθρο" @default.
- Q96302965 description "мақолаи илмӣ" @default.
- Q96302965 description "наукова стаття, опублікована в червні 2020" @default.
- Q96302965 description "научна статия" @default.
- Q96302965 description "научная статья" @default.
- Q96302965 description "научни чланак" @default.
- Q96302965 description "научни чланак" @default.
- Q96302965 description "מאמר מדעי" @default.
- Q96302965 description "مقالة علمية نشرت في 10 يونيو 2020" @default.
- Q96302965 description "১০ জুন ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q96302965 description "บทความทางวิทยาศาสตร์" @default.
- Q96302965 description "სამეცნიერო სტატია" @default.
- Q96302965 name "1Phase I trial of expanded, activated autologous NK cell infusions with trastuzumab in patients with HER2-positive cancers" @default.
- Q96302965 name "1Phase I trial of expanded, activated autologous NK cell infusions with trastuzumab in patients with HER2-positive cancers" @default.
- Q96302965 type Item @default.
- Q96302965 label "1Phase I trial of expanded, activated autologous NK cell infusions with trastuzumab in patients with HER2-positive cancers" @default.
- Q96302965 label "1Phase I trial of expanded, activated autologous NK cell infusions with trastuzumab in patients with HER2-positive cancers" @default.
- Q96302965 prefLabel "1Phase I trial of expanded, activated autologous NK cell infusions with trastuzumab in patients with HER2-positive cancers" @default.
- Q96302965 prefLabel "1Phase I trial of expanded, activated autologous NK cell infusions with trastuzumab in patients with HER2-positive cancers" @default.
- Q96302965 P1433 Q96302965-7301350E-7F31-4D08-B5F2-C5982DD7E2DC @default.
- Q96302965 P1476 Q96302965-CC7C040D-0894-4D34-BFA6-BE235718862C @default.
- Q96302965 P2093 Q96302965-4025AA59-ED1D-494E-9555-BDA49B893CA9 @default.
- Q96302965 P2093 Q96302965-47467F4B-827D-4435-89AB-72D54E9A85DC @default.
- Q96302965 P2093 Q96302965-5ECF4624-28C9-46C6-9579-E95A55BCA9D9 @default.
- Q96302965 P2093 Q96302965-620E6A0D-39EE-4BBD-A185-F429399BBAEE @default.
- Q96302965 P2093 Q96302965-672F4A34-3FA8-4A37-950D-8237FE579FC6 @default.
- Q96302965 P2093 Q96302965-6736E0C6-30CD-48F2-9D4C-FD158EEB5A79 @default.
- Q96302965 P2093 Q96302965-6772B28B-CD97-410C-A21E-3CA9DAD96390 @default.
- Q96302965 P2093 Q96302965-6AC3BD99-C135-4DCF-8C3A-C91A433CD785 @default.
- Q96302965 P2093 Q96302965-7E24A7E1-293F-41B3-B499-A4EE42C0F4ED @default.
- Q96302965 P2093 Q96302965-888B9492-250E-4A83-951C-0C16F3A012D4 @default.
- Q96302965 P2093 Q96302965-896ED308-885A-48BD-858B-E058D348B901 @default.
- Q96302965 P2093 Q96302965-8CB15FFB-97F1-42BD-91D0-AB9C92B0E73A @default.
- Q96302965 P2093 Q96302965-8D025037-5939-4E59-B977-0D5293D39625 @default.
- Q96302965 P2093 Q96302965-964262B6-8E06-4FBB-8607-CAE879286AA7 @default.
- Q96302965 P2093 Q96302965-B85EAE82-DFEE-4BD4-8C71-157CD9154AB7 @default.
- Q96302965 P2093 Q96302965-E1753871-EBA7-46C0-AC06-8C744121968B @default.
- Q96302965 P2093 Q96302965-F456B173-0C3F-4EDE-B62E-5E7AF80D1118 @default.
- Q96302965 P31 Q96302965-055AD7F7-A561-4E14-BD54-AFDCE66311E2 @default.
- Q96302965 P356 Q96302965-13A46996-97A4-4887-80DE-59134E9C3154 @default.
- Q96302965 P50 Q96302965-63D52452-0812-455B-9825-6770E451C977 @default.
- Q96302965 P50 Q96302965-CC0D8EC8-E70D-4620-AE32-C59731DC2FA6 @default.
- Q96302965 P50 Q96302965-CDB0CFFE-E237-4476-9FE1-EADBAF27C9B7 @default.
- Q96302965 P50 Q96302965-DBE2A1AB-0805-4C9D-87C8-4C94043A1746 @default.
- Q96302965 P50 Q96302965-DE50608F-873E-4429-9938-46AEB5C4E047 @default.
- Q96302965 P50 Q96302965-F03E40AA-2488-485E-9738-C3861102BF5B @default.
- Q96302965 P577 Q96302965-9759EFA8-0387-4597-897B-42B054952FA5 @default.
- Q96302965 P698 Q96302965-10E56D2F-BE52-433B-B833-8B870229AC7F @default.
- Q96302965 P921 Q96302965-8DF2BBED-6315-4018-93E0-A40285090FA6 @default.
- Q96302965 P356 1078-0432.CCR-20-0768 @default.
- Q96302965 P698 32522887 @default.
- Q96302965 P1433 Q332253 @default.
- Q96302965 P1476 "1Phase I trial of expanded, activated autologous NK cell infusions with trastuzumab in patients with HER2-positive cancers" @default.